Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1

American Journal of Physiology - Renal Physiology - Tập 293 Số 5 - Trang F1564-F1570 - 2007
Moto Kajiwara1, Tomohiro Terada, Junichi Asaka, K. OGASAWARA, Toshiya Katsura, Osamu Ogawa, Atsushi Fukatsu, Toshio Doi, Ken‐ichi Inui
1Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan

Tóm tắt

A H+/organic cation antiporter (multidrug and toxin extrusion 1: MATE1/SLC47A1) plays important roles in the tubular secretion of various clinically important cationic drugs such as cimetidine. We have recently found that the regulation of this transporter greatly affects the pharmacokinetic properties of cationic drugs in vivo. No information is available about the regulatory mechanisms for the MATE1 gene. In the present study, therefore, we examined the gene regulation of human (h) and rat (r) MATE1, focusing on basal expression. A deletion analysis suggested that the regions spanning −65/−25 and −146/−38 were essential for the basal transcriptional activity of the hMATE1 and rMATE1 promoter, respectively, and that both regions contained putative Sp1-binding sites. Functional involvement of Sp1 was confirmed by Sp1 overexpression, a mutational analysis of Sp1-binding sites, mithramycin A treatment, and an electrophoretic mobility shift assay. Furthermore, we found a single nucleotide polymorphism (SNP) in the promoter region of hMATE1 (G−32A), which belongs to a Sp1-binding site. The allelic frequency of this rSNP was 3.7%, and Sp1-binding and promoter activity were significantly decreased. This is the first study to clarify the transcriptional mechanisms of the MATE1 gene and to identify a SNP affecting the promoter activity of hMATE1.

Từ khóa


Tài liệu tham khảo

10.1007/s11095-006-9665-2

Asaka J, Terada T, Tsuda M, Katsura T, Inui K. Identification of essential histidine and cysteine residues of H+/organic cation antiporter, multidrug and toxin extrusion (MATE). Mol Pharmacol 46: 1487–1493, 2007.

10.1128/MCB.10.12.6632

10.1172/JCI115474

10.1016/S0303-7207(02)00221-6

10.1016/j.bbadis.2005.10.004

10.1152/ajpheart.2000.278.3.H853

10.1016/j.bbrc.2006.12.151

Fouda AK, Fauth C, Roch-Ramel F. Transport of organic cations by kidney epithelial cell line LLC-PK1. J Pharmacol Exp Ther 252: 286–292, 1990.

10.1042/BJ20051802

10.1038/ng1096-130

10.1038/372549a0

10.1196/annals.1377.020

10.1046/j.1523-1755.2000.00251.x

10.1042/bj2270199

10.1016/j.clpt.2006.01.011

10.1152/ajpgi.2000.278.4.G591

10.1073/pnas.88.13.5670

10.1681/ASN.2006030205

10.1016/j.bcp.2006.12.034

10.1016/j.bbrc.2006.12.126

10.1152/ajprenal.00017.2007

10.1124/dmd.106.010876

10.1086/424761

10.1073/pnas.0506483102

10.1101/gad.5.11.1935

10.1172/JCI114110

10.1152/ajpcell.1992.262.1.C59

10.1152/ajpcell.00130.2005

10.1016/j.bcp.2006.03.001

Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP, Sheardown SA, Yue L, Burchard EG, Brett CM, Giacomini KM. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther. In press.

10.1172/JCI30558

10.1016/j.bcp.2007.04.010

10.1007/s11095-006-9016-3

Tsuda M, Terada T, Asaka J, Ueba M, Katsura T, Inui K. Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1. Am J Physiol Renal Physiol 292: F593–F598, 2007.

10.1016/j.taap.2004.10.021

10.1152/ajprenal.00102.2007